MAB1381

antibody from R&D Systems

Targeting: KLRC2 CD159c, NKG2-C

Flow cytometry (Recommended by provider)

Antibody Data

Product number

MAB1381

Provider

R&D Systems

Product name

Anti-Human NKG2C/CD159c Monoclonal Antibody (Clone 134522)

Antibody type

Monoclonal

Antigen

BaF3 mouse pro-B cell line transfected with human NKG2C/CD159c and CD94

Description

Protein A or G purified from hybridoma culture supernatant

Reactivity

Human

Host

Mouse

Isotype

IgG

Vial size

500 µg

References

Submitted references

Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway.

Ye W, Chew M, Hou J, Lai F, Leopold SJ, Loo HL, Ghose A, Dutta AK, Chen Q, Ooi EE, White NJ, Dondorp AM, Preiser P, Chen J
PLoS pathogens 2018 Oct;14(10):e1007298

---

Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

Redondo-Pachón D, Crespo M, Yélamos J, Muntasell A, Pérez-Sáez MJ, Pérez-Fernández S, Vila J, Vilches C, Pascual J, López-Botet M
Journal of immunology (Baltimore, Md. : 1950) 2017 Jan 1;198(1):94-101

---

NFKB1 regulates human NK cell maturation and effector functions.

Lougaris V, Patrizi O, Baronio M, Tabellini G, Tampella G, Damiati E, Frede N, van der Meer JWM, Fliegauf M, Grimbacher B, Parolini S, Plebani A
Clinical immunology (Orlando, Fla.) 2017 Feb;175:99-108

---

Experimental Zika Virus Inoculation in a New World Monkey Model Reproduces Key Features of the Human Infection.

Chiu CY, Sánchez-San Martín C, Bouquet J, Li T, Yagi S, Tamhankar M, Hodara VL, Parodi LM, Somasekar S, Yu G, Giavedoni LD, Tardif S, Patterson J
Scientific reports 2017 Dec 7;7(1):17126

---

NK Cell Proliferation Induced by IL-15 Transpresentation Is Negatively Regulated by Inhibitory Receptors.

Anton OM, Vielkind S, Peterson ME, Tagaya Y, Long EO
Journal of immunology (Baltimore, Md. : 1950) 2015 Nov 15;195(10):4810-21

---

Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.

Horowitz A, Guethlein LA, Nemat-Gorgani N, Norman PJ, Cooley S, Miller JS, Parham P
Journal of immunology (Baltimore, Md. : 1950) 2015 Nov 1;195(9):4524-36

---

Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus.

Costa-Garcia M, Vera A, Moraru M, Vilches C, López-Botet M, Muntasell A
Journal of immunology (Baltimore, Md. : 1950) 2015 Mar 15;194(6):2715-24

---

Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.

Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG
The Journal of biological chemistry 2013 Mar 22;288(12):8679-90

---

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components.

Alici E, Sutlu T, Björkstrand B, Gilljam M, Stellan B, Nahi H, Quezada HC, Gahrton G, Ljunggren HG, Dilber MS
Blood 2008 Mar 15;111(6):3155-62

---

Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation.

Coupel S, Moreau A, Hamidou M, Horejsi V, Soulillou JP, Charreau B
Blood 2007 Apr 1;109(7):2806-14